Non surgical management of cystic lymphangioma

Autor:	S. N. Kureel, Jiledar Rawat, Ravi Prakash Kanojia, Shandip K. Sinha, R. K. Tandon, Asish Wakhlu
Rok vydání:	2006
Předmět:	medicine.medical_specialty business.industry Bleomycin Injection Bleomycin medicine.disease Surgery chemistry.chemical_compound Axilla medicine.anatomical_structure Otorhinolaryngology chemistry Lymphangioma Head and neck surgery Medicine business Main Article
Zdroj:	Indian Journal of Otolaryngology and Head and Neck Surgery. 58:355-357
ISSN:	0973-7707 0019-5421
DOI:	10.1007/bf03049593
Popis:	Aim/Purpuse: To evaluate our experience of 19 patients of lymphangioma who were treated by intralesional Bleomycin.Materials and Methods: Nineteen patients of lymphangioma aged between 16 days to 11 years were managed in the department. The male-female ratio was of 2:1. Commonest sites were in the neck (58%) followed by axilla (21%). The patients were treated by intralesional bleomycin injection. Bleomycin was given at a dose not exceeding 0.5 unit/kg/dose at interval of 2 weeks. Reduction in size of the mass was noted in between 2 weeks to 16 weeks and number of injections required for each patient varied from 1 to 6. Follow up ranged from 1– 7 Year.Result: In injection group, significant reduction of mass was noted in 84% (n=l6) and 57% (n=11) of them showed complete disappearance. No serious complications were noted in any patient.Conclusion: Our experience showed that Bleomycin in aqueous solution is a good sclcrosing agent in the management of lymphangioma.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::288c6e0ed2e3bed63fba9a7d44a8983a https://doi.org/10.1007/bf03049593 Zobrazit plný text záznamu Plný text ve formátu PDF